A. S. Prilutskiy & O. A. Prilutskaia. (2024). Use of omalizumab and allergen-specific immunotherapy for the treatment of respiratory allergic diseases in children and adults. Association of Paediatric Allergists and Immunologists of Russia (APAIR).
Chicago Style (17th ed.) CitationA. S. Prilutskiy and O. A. Prilutskaia. Use of Omalizumab and Allergen-specific Immunotherapy for the Treatment of Respiratory Allergic Diseases in Children and Adults. Association of Paediatric Allergists and Immunologists of Russia (APAIR), 2024.
MLA (9th ed.) CitationA. S. Prilutskiy and O. A. Prilutskaia. Use of Omalizumab and Allergen-specific Immunotherapy for the Treatment of Respiratory Allergic Diseases in Children and Adults. Association of Paediatric Allergists and Immunologists of Russia (APAIR), 2024.